Table 1 Demographics and psychosocial data in discovery cohort at baseline and during follow-up.
AeYA cancer survivors completing 3-year follow-up | Total (n = 923) | Incident depression (n = 267) | Control (n = 656) | Test | P | |
|---|---|---|---|---|---|---|
Sex | Male | 440 (47.7) | 120 (44.9) | 320 (48.8) | χ2 = 1.12 | 0.29 |
female | 483 (52.3) | 147 (55.1) | 336 (51.2) | |||
Age, M(SD) | 20.3 (2.74) | 20.02 (2.77) | 20.42 (2.73) | t = 2.03 | 0.67 | |
Diagnosis | Leukemia | 446 (48.3) | 129 (48.3) | 317 (48.3) | χ2 = 1.04 | 0.59 |
Lymphoma | 440 (47.7) | 130 (48.7) | 310 (47.3) | |||
Sarcoma | 37 (4.0) | 8 (3.0) | 29 (4.4) | |||
Course of diseasea (month), M(SD) | 29.32 (5.26) | 29.41 (5.14) | 29.29 (5.32) | t = −0.31 | 0.29 | |
Psychiatric history | Yes | 207 (22.4) | 54 (20.2) | 153 (23.3) | χ2 = 1.05 | 0.31 |
No | 716 (77.6) | 213 (79.8) | 503 (76.7) | |||
Household Income, yearly (10,000 yuan) | <2 | 274 (29.7) | 71 (26.6) | 203 (30.9) | χ2 = 2.41 | 0.49 |
2-10 | 325 (35.2) | 98 (36.7) | 227 (34.6) | |||
10-20 | 130 (14.1) | 36 (13.5) | 94 (14.3) | |||
>20 | 194 (21.0) | 62 (23.2) | 132 (20.1) | |||
FACT-G scoreb, M(SD) | 94.87 (7.91) | 92.91 (9.02) | 95.66 (7.27) | t = 4.85 | <0.001 | |
BDI scoreb, M(SD) | 3.88 (2.46) | 4.51 (2.78) | 3.62 (2.27) | t = −5.04 | <0.001 | |
Current schoolingb | Yes | 645 (69.9) | 184 (68.9) | 461 (70.3) | χ2 = 0.17 | 0.68 |
No | 278 (30.1) | 83 (31.1) | 195 (29.7) | |||
Relapse during remission | Yes | 189 (20.5) | 64 (24.0) | 125 (19.1) | χ2 = 2.82 | 0.09 |
No | 734 (79.5) | 203 (76.0) | 531 (80.9) | |||
Multiple relapses | Yes | 576 (62.4) | 167 (62.5) | 409 (62.3) | χ2 = 0.003 | 0.96 |
No | 347 (37.6) | 100 (37.5) | 247 (37.7) | |||
